News
DMAAR
0.1350
+11.57%
0.0140
Drugs Made In America Acquisition swings to Q1 FY26 profit of $1.97 million
PUBT · 1d ago
Drugs Made in America Acquisition II swings to Q1 FY26 net income of $4.34 million
PUBT · 1d ago
Drugs Made In America Acquisition agrees to merge with Power Analytics Global in $1 billion deal
PUBT · 05/05 21:39
Drugs Made In America Acquisition held shareholder meeting on extension amendment proposal
PUBT · 05/01 21:06
Drugs Made in America Acquisition II sets CEO pay at $4,500 monthly, 250,000 shares
PUBT · 04/28 21:27
Drugs Made In America Acquisition sets CEO pay at $4,500 monthly plus 250,000 shares
PUBT · 04/28 21:09
Drugs Made in America Acquisition II posts FY25 net income of $4.2 million
PUBT · 04/15 20:11
DRUGS MADE IN AMERICA ACQUISITION CORP SAYS DEAL ANTICIPATED TO VALUE POWER ANALYTICS GLOBAL CORP AT $1.0 BLN - SEC FILING
Reuters · 04/08 13:03
Drugs Made In America Acquisition signs LOI to merge with Power Analytics Global at $1 billion valuation
Reuters · 04/08 13:01
Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal
Reuters · 04/03 20:34
Drugs Made In America Acquisition delays 10-K filing, targets April 15 submission
Reuters · 04/01 20:06
Drugs Made in America Acquisition II delays annual report filing, targets April 15 deadline
Reuters · 04/01 20:06
Drugs Made In America Acquisition Corp. announced an extraordinary general meeting
Reuters · 03/27 20:58
Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total
Reuters · 03/27 20:08
Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office
Reuters · 03/17 20:02
Drugs Made In America Acquisition Corp. Confirms $241.3 Million in Trust Account
Reuters · 03/06 22:02
DRUGS MADE IN AMERICA ACQUISITION CORP - ON NOV 17, APPOINTED SALEEM ELMASRI AS CHIEF FINANCIAL OFFICER - SEC FILING
Reuters · 11/18/2025 11:04
Drugs Made In America Acquisition Corp. Appoints Saleem Elmasri as Chief Financial Officer
Reuters · 11/18/2025 11:02
Drugs Made In America Acquisition Corp. Delays Quarterly Financial Report
Reuters · 11/17/2025 11:26
Drugs Made In America Acquisition II LLC Reports Disposal of Common Shares of Drugs Made in America Acquisition II Corp
Reuters · 10/01/2025 14:38
More
Webull provides a variety of real-time DMAAR stock news. You can receive the latest news about Drugs Made In Amer Acqutn Corp through multiple platforms. This information may help you make smarter investment decisions.
About DMAAR
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.